CHEN YANG is a partner in the firm’s Beijing office, where she heads the firm’s China Life Sciences practice. Ms. Yang focuses on regulatory, corporate and commercial law. She represents international pharmaceutical, medical device and food companies in connection with market entrance, marketing and promotional activities, product recalls, clinical trials, FCPA / Anti-bribery and other industry-specific regulatory, compliance and enforcement issues, as well as joint ventures, merger and acquisitions, licensing, IP and antitrust matters.

Over the last 15 years, Ms. Yang has been representing international companies on their investment projects and acquisition efforts in various Chinese industries, as well as assisting on regulatory matters in areas such as employment, tax and real estate. In recent years, she has been dedicated to corporate, transactional and regulatory matters for multinational life sciences companies. Ms. Yang also assisted P.R.C. government agencies with respect to U.S. litigation. Prior to entering private practice, she worked as a legislative official in the Bureau of Legislative Affairs of the State Council, one of China’s main legislation drafting bodies, as well as in the anti-corruption bureau of a local procuratorate in Beijing.

Ms. Yang is highly ranked in the “China/Hong Kong: Corporate/Commercial” category in PLC’s Which Lawyer survey of leading Life Science lawyers worldwide. She has also been named as a leading lawyer for Mergers and Acquisitions work in China by IFLR 1000, as well as for Life Sciences work in China/Hong Kong by Chambers Asia. Ms. Yang frequently speaks at national and international industry conferences and seminars.